You are here: Home 
Categories Investigative Urology
Categories Investigative Urology An epirubicin-conjugated nanocarrier with MRI function to overcome lethal multidrug-resistant bladder cancer - Abstract
An epirubicin-conjugated nanocarrier with MRI function to overcome lethal multidrug-resistant bladder cancer - Abstract
Published on 17 April 2012
Multidrug resistance (MDR) presents a major obstacle to curing cancer.
To read more, a FREE Urotoday registration is required. Click here to register or login above.To read UIJ content, a separate subscription is required.
Tags: